Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Cauli

Showing results (71-80 of 180) with videos related to

Pageof 18
Sort By:
Clinical and Experimental Rheumatology|February 25, 2011
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanerceptEnnio Lubrano, Antonio Spadaro, Antonio Marchesoni, et al.
Current Pharmaceutical Design|January 8, 2021
Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis?Arduino A Mangoni, Sara Tommasi, Salvatore Sotgia, et al.
Healthcare (Basel, Switzerland)|January 23, 2024
Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive EpisodesDiego Primavera, Mauro Giovanni Carta, Ferdinando Romano, et al.
Clinical and Experimental Rheumatology|May 28, 2026
Behçet's syndrome incidence and prevalence in Sardinia: implications of a latent class analysis combining administrative and clinical dataMatteo Piga, Davide Corradini, Pietro Carboni, et al.
Clinical and Experimental Rheumatology|September 13, 2011
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for RheumatologyCarlo Salvarani, Nicolò Pipitone, Antonio Marchesoni, et al.
Clinical and Experimental Rheumatology|November 30, 2017
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of RheumatologyAntonio Marchesoni, Ignazio Olivieri, Carlo Salvarani, et al.
The Journal of Rheumatology|April 1, 2009
Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritisEnnio Lubrano, Antonio Marchesoni, Ignazio Olivieri, et al.
Medicine|April 28, 2021
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort studyAlberto Floris, Daniela Perra, Ignazio Cangemi, et al.
Journal of Imaging Informatics in Medicine|February 12, 2026
Machine Learning for MRI Classification of Systemic Lupus Erythematous Patients with and without Neuropsychiatric EventsSebastiano Vacca, Gianluca Chabert, Matteo Piga, et al.
Rheumatology (Oxford, England)|January 6, 2021
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI patternMatteo Piga, Mattia Congia, Antonella Balestrieri, et al.
Pageof 18

Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
Clinical and Experimental Rheumatology|February 25, 2011
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanerceptEnnio Lubrano, Antonio Spadaro, Antonio Marchesoni, et al.
Current Pharmaceutical Design|January 8, 2021
Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis?Arduino A Mangoni, Sara Tommasi, Salvatore Sotgia, et al.
Healthcare (Basel, Switzerland)|January 23, 2024
Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive EpisodesDiego Primavera, Mauro Giovanni Carta, Ferdinando Romano, et al.
Clinical and Experimental Rheumatology|May 28, 2026
Behçet's syndrome incidence and prevalence in Sardinia: implications of a latent class analysis combining administrative and clinical dataMatteo Piga, Davide Corradini, Pietro Carboni, et al.
Clinical and Experimental Rheumatology|September 13, 2011
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for RheumatologyCarlo Salvarani, Nicolò Pipitone, Antonio Marchesoni, et al.
Clinical and Experimental Rheumatology|November 30, 2017
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of RheumatologyAntonio Marchesoni, Ignazio Olivieri, Carlo Salvarani, et al.
The Journal of Rheumatology|April 1, 2009
Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritisEnnio Lubrano, Antonio Marchesoni, Ignazio Olivieri, et al.
Medicine|April 28, 2021
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort studyAlberto Floris, Daniela Perra, Ignazio Cangemi, et al.
Journal of Imaging Informatics in Medicine|February 12, 2026
Machine Learning for MRI Classification of Systemic Lupus Erythematous Patients with and without Neuropsychiatric EventsSebastiano Vacca, Gianluca Chabert, Matteo Piga, et al.
Rheumatology (Oxford, England)|January 6, 2021
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI patternMatteo Piga, Mattia Congia, Antonella Balestrieri, et al.
Pageof 18